Table 1.
Feature | Card11−/− | Card11un/un | Bcl10−/− | Malt1−/− | Malt1PD/PD |
---|---|---|---|---|---|
B CELLS | |||||
Populations | |||||
Total | Normal | Normal | Normal | Normal | Normal |
FO | Normal | Normal | ↓ | Normal | Normal |
MZ | ↓ | Normal | ↓ | ↓ | ↓ |
B1 | ↓ | ↓ | ↓ | ↓ | ↓ |
GC | ND | ND | ND | ↓ | ↓ |
Proliferation | |||||
IgM | ↓ | ↓ | ↓ | ↓ | Normal |
CD40 | ↓ | ↓ | ↓ | ↓ | ND |
CD40L | ND | ND | ND | ↓ | ↓ |
IgM+CD40 | ↓ | ND | ↓ | ND | ND |
LPS | ↓ | Normal | Normal | ↓ or normal | ↓ or normal |
IgM+IL-4 | ND | ↓ | ND | ↓ | ↓ |
CD40+IL-4 | ND | ↓ | ND | ↓ or normal | Normal |
Signaling | |||||
IκBα/NF-κB | ↓ | ↓ | ↓ | ↓ or normal | Normal |
JNK | ↓ | ↓ | ↓ | ↓ or normal | ↓ or normal |
ERK | Normal | Normal | Normal | Normal | Normal |
Tyrosine | Normal | Normal | ND | Normal | ND |
Calcium | Normal | Normal | Normal | ND | ND |
T CELLS | |||||
Populations | |||||
Total | Normal | Normal | Normal | Normal | Normal |
CD4 | Normal | Normal | Normal | Normal | Normal |
CD8 | Normal | Normal | Normal | Normal | Normal |
Treg | ↓ | ↓ | ↓ | ↓ | ↓ |
Th1 | ↓ | Normal | ND | ↑ or normal | ↑ |
Th2 | ↓ | ↑ | ND | ↑ or normal | ↑ |
Th17 | ↓ | Normal | ND | ↓ or normal | ↑ |
Tfh | ND | ND | ND | ↓ | ↓ |
NKT | Normal | ND | Normal | ND | ND |
DN3 | ↓ | ND | ND | ↓ | ND |
DN4 | ↑ | ND | ↑ | ↑ | ↑ |
DP | ND | ND | ↓ | Normal | Normal |
Proliferation | |||||
CD3 | ↓ | Normal | ↓ | ↓ | ↓ |
CD3+CD28 | ↓ | ↓ | ↓ | ↓ | ↓ |
P/I | ↓ | ND | ↓ | ↓ | ND |
Signaling | |||||
IκBα/NF-κB | ↓ | ND | ↓ | ↓ | Normal |
JNK | ↓ | ND | ND | ↓ | ↓ or normal |
ERK | Normal | ND | Normal | Normal | Normal |
Tyrosine | Normal | ND | Normal | Normal | ND |
Calcium | Normal | ND | Normal | ND | ND |
Activation Markers (α-CD3+CD28) | |||||
CD25 | ↓ | ↓ | ↓ | ↓ | Normal |
CD69 | ↓ | ↓ | ↓ | ↓ | ND |
CD40L | ND | ↓ | ND | ND | ND |
OX40 | ND | ↓ | ND | ND | ND |
ICOS | ND | ↓ | ND | ND | ND |
CD44 | ↓ | ND | ↓ | ↓ | ND |
IMMUNOGLOBULINS | |||||
Basal | |||||
IgM | ↓ | ↓ | ↓ | ↓ | ↓ |
IgG1 | ↓ | Normal | ↓ | ↓ | ↑ |
IgG2a | ↓ | ND | ↓ | ↓ | ↓ |
IgG2b | ↓ | Normal | ↓ | ↓ | ↓ |
IgG3 | ↓ | ↓ | ↓ | ↓ | ↓ |
IgA | ↓ | ND | ↓ | ↓ or normal | Normal |
IgE | ND | ↑ | ND | ND | ↑ |
T-dependent | |||||
IgM | ↓ | ↓ | ↓ | ↓ | ↓ |
IgG1 | ↓ | ↓ | ↓ | ↓ | ↓ |
IgG2a | ↓ | ND | ↓ | ND | ND |
IgG2b | ND | ND | ↓ | ND | ND |
IgG3 | ND | ND | ↓ | ND | ND |
Other immune manifestations | None | Atopy and dermatitis with age | None | None | Spontaneous multi-organ inflammation |
References | (11, 12, 81–84) | (13, 17, 85) | (14, 15, 86, 87) | (16, 88–90) | (89, 91–93) |
Lymphocyte characteristics, immunoglobulin levels, and additional immune features are summarized and compared for Card11−/−, Card11un/un, Bcl10−/−, Malt1−/−, Malt1PD/PD mice. ND, no data; ↑, increased levels relative to normal range; ↓, decreased levels relative to normal range; FO, follicular B cell; MZ, marginal zone B cell; GC, germinal center B cell; LPS, lipopolysaccharide; IL-4, interleukin 4; IκBα, NF-κB inhibitor alpha; NF-κB, nuclear factor kappa B; Treg, T regulatory cell; Th, T helper cell; Tfh, T follicular helper cell; NKT, natural killer T cell; DN, double negative; DP, double positive; P/I, phorbol 12-myristate 13-acetate (PMA) / ionomycin; JNK, c-Jun N-terminal kinase; ERK, extracellular signal-regulated kinase; ICOS, inducible T cell costimulatory.